Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.


CSE:AGN - Post by User

Post by homerunstockon Oct 27, 2019 1:35am
100 Views
Post# 30273756

Ignore the sore losers here & prosper !!

Ignore the sore losers here & prosper !!Smart traders would have bought BLO at .20 and rode it to to $3.00 same with Algernon now ignore the whining sore losers dont let there constant negative bashing bring you down this will go from .085 to .40 quickly as such buy low sell high - Facts are only very few become revenue producing gems we hope for - all these companies are built on speculation and hope - So you have to learn the game and prosper - so quit complaing about this and that with this group or that group because most are like this as such use it to your advantage - Buy low is key that is your protection as per Algernan i would say buying at .085 and selling at minimum .17 once financing closes i expect news flow to start as it does with all plays - So ride the wave dont fight it as a big part of microcap plays all act this way - learn and prosper - ignore the same constant bashers who dont know how to play the microcap speculating game !!
Bullboard Posts